Anatra Tablet
FDA Label NDC 83641-001

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Anatra Llc for the product Anatra (NDC 83641-001). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredient, purpose, uses, warnings, directions, other information, inactive ingredients, questions/comments?, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

Active Ingredient

Anas barbariae. HPUS - 200 CK

Purpose

To reduce the duration and severity of cold & flu-like symptoms. The letters HPUS indicate that this ingredient is officially included in the Homeopathic Pharmacopeia of the United States.

Uses

Temporarily relieves cold & flu-like symptoms such as:

  • Body aches
  • Headache
  • Fever
  • Chills
  • Fatigue

Warnings

Ask a Doctor before usein children under 2 years of age.
Stop use and ask a Doctor if symptoms persist for more than 3 days or worsen.
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children.

Directions

ANATRA may be taken regularly as a preventative.
Adults and children 2 years of age and older: Dissolve entire tablet in mouth every
6 hours, up to 3 times a day. Children under two years of age: Ask a Doctor.

Other Information

Do not use if carton is open and/or bottle is open.Each 0.775g dose contains 0.5g of sugar. Store at 68-77°F (20-25°C).

Inactive Ingredients

Beta Carotene, Citric Acid, Crospovidone, Dextrose,Lactose, Magnesium Stearate, Nat. Orange Flavor, Reb. A (Stevia LeafExtract), Silicon Dioxide, Stearic Acid

Questions/Comments?

Distributed by Anatra LLC 3250 NE 1st Ave., Suite 305 Miami, FL 33137 (844) ANATRA-1

Product Label

Image Description (Image 30tab 1)

Image Description (Image 30tab 1)

Image Description (Image 30tab 2)

Image Description (Image 30tab 2)

Image Description (Image 60tab 2)

Image Description (Image 60tab 2)

Image Description (Image 60tab 1)

Image Description (Image 60tab 1)

* Please review the disclaimer below.